193 related articles for article (PubMed ID: 30672666)
21. Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization.
McNamara M; Felix C; Davison EV; Fenton M; Kennedy SM
Cancer Genet Cytogenet; 1997 Oct; 98(1):4-8. PubMed ID: 9309111
[TBL] [Abstract][Full Text] [Related]
22. Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.
Xu S; Yang Z; Zhang J; Jiang Y; Chen Y; Li H; Liu X; Xu D; Chen Y; Yang Y; Zhang Y; Li D; Xia J
DNA Cell Biol; 2015 Jan; 34(1):69-77. PubMed ID: 25343173
[TBL] [Abstract][Full Text] [Related]
23. Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for
Anbunathan H; Verstraten R; Singh AD; Harbour JW; Bowcock AM
Clin Cancer Res; 2019 Aug; 25(16):5156-5166. PubMed ID: 31227497
[TBL] [Abstract][Full Text] [Related]
24. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
[TBL] [Abstract][Full Text] [Related]
25. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
[TBL] [Abstract][Full Text] [Related]
26. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma.
Asnaghi L; Alkatan H; Mahale A; Othman M; Alwadani S; Al-Hussain H; Jastaneiah S; Yu W; Maktabi A; Edward DP; Eberhart CG
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8604-13. PubMed ID: 25491297
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
28. Variation of mutant allele frequency in NRAS Q61 mutated melanomas.
Hélias-Rodzewicz Z; Funck-Brentano E; Terrones N; Beauchet A; Zimmermann U; Marin C; Saiag P; Emile JF
BMC Dermatol; 2017 Jul; 17(1):9. PubMed ID: 28668077
[TBL] [Abstract][Full Text] [Related]
29. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
30. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract][Full Text] [Related]
31. Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.
Rossi E; Schinzari G; Maiorano BA; Pagliara MM; Di Stefani A; Bria E; Peris K; Blasi MA; Tortora G
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683701
[TBL] [Abstract][Full Text] [Related]
32. Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey.
Mikkelsen LH; Larsen AC; von Buchwald C; Drzewiecki KT; Prause JU; Heegaard S
APMIS; 2016 Jun; 124(6):475-86. PubMed ID: 27004972
[TBL] [Abstract][Full Text] [Related]
33. Role of Elevated
Bezrookove V; Nosrati M; Miller JR; De Semir D; Dar AA; Vosoughi E; Vaquero E; Sucker A; Lazar AJ; Gershenwald JE; Davies MA; Schadendorf D; Kashani-Sabet M
Clin Cancer Res; 2018 Sep; 24(17):4119-4125. PubMed ID: 29776954
[No Abstract] [Full Text] [Related]
34. Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma.
Sanna A; Harbst K; Johansson I; Christensen G; Lauss M; Mitra S; Rosengren F; Häkkinen J; Vallon-Christersson J; Olsson H; Ingvar Å; Isaksson K; Ingvar C; Nielsen K; Jönsson G
Pigment Cell Melanoma Res; 2020 May; 33(3):480-489. PubMed ID: 31811783
[TBL] [Abstract][Full Text] [Related]
35. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
36. Genomic and transcriptomic landscape of conjunctival melanoma.
Cisarova K; Folcher M; El Zaoui I; Pescini-Gobert R; Peter VG; Royer-Bertrand B; Zografos L; Schalenbourg A; Nicolas M; Rimoldi D; Leyvraz S; Riggi N; Moulin AP; Rivolta C
PLoS Genet; 2020 Dec; 16(12):e1009201. PubMed ID: 33383577
[TBL] [Abstract][Full Text] [Related]
37. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
[TBL] [Abstract][Full Text] [Related]
38. T1799A BRAF mutations in conjunctival melanocytic lesions.
Goldenberg-Cohen N; Cohen Y; Rosenbaum E; Herscovici Z; Chowers I; Weinberger D; Pe'er J; Sidransky D
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3027-30. PubMed ID: 16123397
[TBL] [Abstract][Full Text] [Related]
39. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract][Full Text] [Related]
40. The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
Appenzeller S; Gesierich A; Thiem A; Hufnagel A; Jessen C; Kneitz H; Regensburger M; Schmidt C; Zirkenbach V; Bischler T; Schilling B; Siedel C; Goebeler ME; Houben R; Schrama D; Gehrig A; Rost S; Maurus K; Bargou R; Rosenwald A; Schartl M; Goebeler M; Meierjohann S
Cancer; 2019 Feb; 125(4):586-600. PubMed ID: 30561760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
